Risk Partners Life Sciences Roundtable 2025, thank you very much! 

Your Risk.
Our DNA.

With Atrialis - experts for clinical trials, we have been successfully supporting our clients in the market since 2007. With the founding of Risk Partners in 2023, we have significantly expanded our range of services once again. We are specialized and aim to be the market leader in these specializations for game changers. Accordingly, we are regularly involved in important topics for you or network with important trendsetters in our specializations. We are happy to keep you up to date with our developments so that you can regularly read new articles here.  

News from Risk Partners -
For you in our specialist areas

Capital requirements for (fully regulated) AIFMs

What are the capital requirements for an asset management company? Together with experts Johannes Kiefer (Director of Risk & Compliance at Landsiedel & Partner) and Henry Franz (Managing Director of Layline.tax), we were able to compile our complementary expertise on capital requirements, ranging from registered asset management companies to fully licensed ones. In this issue of VC Magazine, we share how E&O insurance, among other things, can provide added value. In addition to our article available below, please also see the

Read more "

Risk Partners is advising Terranor Group AG on its NASDAQ (Sweden) IPO

From Road Builder to IPO Candidate: How Terranor Group AB Conquered Nasdaq First North. It was a day that marked a new chapter not only for Terranor Group AB but for the entire Nordic infrastructure sector: On June 19, 2025, the Swedish company celebrated its successful initial public offering on the Nasdaq First North Premier Growth Market in Stockholm. Risk Partners as IPO Advisor Because while Terranor Group’s shares

Read more "

New: Risk Partners POSI Insurance for MiCAR White Paper

MiCAR Compliance? We Cover the Risk! The MiCAR Regulation (EU 2023/1114) exposes crypto-asset service providers and whitepaper authors to significant liability risks. Incomplete, inaccurate, or misleading information in white papers can have significant consequences for Crypto-Asset Service Providers (CASP) and authors—ranging from regulatory sanctions to civil claims. Our solution: Risk Partners Tech POSI MiCAR Whitepaper Protect 2025 The creation and publication of white papers under MiCAR involves complex liability pitfalls: In addition to

Read more "

Prospectus liability insurance (POSI): Risk Partners publishes for you

Risk Partners on Going Public and the capital market blog on prospectus liability insurance In recent months, we have been able to share our expertise on prospectus liability insurance with a wide audience on two renowned platforms. Here is an overview: Kapitalmarkt.blog In the article "POSI insurance - The protective vest on the capital market", we explain why prospectus liability insurance is an indispensable tool for companies becoming active on the capital market. The article shows in a practical way how such insurance not only minimizes liability risks,

Read more "
4 pillars of cyber insurance for venture capital and private equity

Cyber insurance Venture capital and private equity

Why cyber insurance does not transfer the core risk of VC & PE funds and why we have invested in Risk Partners cyber master agreements. Why cyber risks are relevant for venture capital and private equity funds With the increasing growth of the cyber crime industry (see Federal Office for the Protection of the Constitution), venture capital (VC) and private equity (PE) funds and their fund managers are also increasingly exposed to cyber risks. For years, this has been reflected in the claims we have been able to support, in which fund managers have been exposed to cyber risks year after year.

Read more "

"Digital Operational Resilience Act" (DORA regulation) from the perspective of venture capital and private equity funds

DORA regulation applies from January 2025. Significance for our private equity and venture capital clients The somewhat unwieldy name "Digital Operational Resilience Act" (DORA for short) has a very serious background and is fundamentally to be welcomed. Because when we evaluate our claims in the context of cybercrime, PE and VC funds and their KVGs are those with the highest frequency of claims. This can be safely assumed,

Read more "

Risk Partners supports successful uplisting of Formycon AG to the Prime Standard

We warmly congratulate Formycon AG on its successful uplisting to the Prime Standard of the German Stock Exchange on November 12, 2024! Welcome to the Prime Standard league: A new champion of life sciences and biosimilars has successfully made the step from the scale segment. We proudly congratulate Enno Spillner, Dr. Caroline Redeker, Daniel Marquard and the entire team at Formycon AG on this great success and another important milestone on their way to

Read more "

Risk Partners supports successful IPO of Steyr Motors AG

We congratulate Steyr Motors AG on its successful listing in the Scale Segment of the German Stock Exchange on October 30, 2024! Risk Partners had the honor to act as IPO underwriting advisor on this transaction. Our team, led by Florian Eckstein and Björn Stressenreuter, supported Steyr Motors AG in its IPO on the Frankfurt Stock Exchange. Our expertise and comprehensive support were geared towards providing Steyr Motors with a secure and successful start on the capital markets.

Read more "

Global Integrity and Compliance Forum 2024 

𝗚𝗹𝗼𝗯𝗮𝗹 𝗜𝗻𝘁𝗲𝗴𝗿𝗶𝘁𝘆 𝗮𝗻𝗱 𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 𝗙𝗼𝗿𝘂𝗺 𝟮𝟬𝟮𝟮𝟰 "D&O and Co. - Plan B to cover personal liability!" Last Friday, Florian had the honor of taking part in the Global Integrity and Compliance Forum at the Ludwig-Maximilians-Universität in Munich. Under the motto "The RULE of LAW in the Era of Integrity & Compliance", international legal experts, company managers and in-house councils & compliance officers from all over the world gathered to discuss the future of good corporate governance in the

Read more "

Research breakdown at Stockholm's Karolinska Institute: A cooling failure destroys cell cultures from decades of research

Research mishap at Stockholm's Karolinska Institute: A cooling failure destroys cell cultures from decades of research - can you insure against it? An incident that threatens your very existence, but which we would like to shed some light on from the perspective of an insurance broker specializing in life sciences. What happened? A cooling system at the Karolinska Institute in Stockholm, Sweden's most important medical research center, failed for five days. Biological material that had been collected over 30 years and was, according to the institute, unique in the world was

Read more "

OLG Schleswig – Statute of Limitations for Liability Claims in the Case of Direct Claims in D&O Insurance

/*! elementor – v3.21.0 – 18-04-2024 */ .elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px} OLG Schleswig: Verjährung des Haftungsanspruchs beim Direktanspruch in der D&O-Versicherung. Es gibt ein neues, spannendes Urteil aus der Welt der D&O-Versicherung. Jüngst hatten wir über die Entscheidung des OLG Köln im Kontext der Direktklage berichtet. Nun hat auch das OLG Schleswig eine wegweisende Entscheidung getroffen. Worum ging es? Im Mittelpunkt stand die Frage der Verjährung. Hierbei

Read more "

Finance Day 2024

Growth capital for biotechnology and life sciences - Finance Day 2024 A few days ago, Jutta and Florian from our team attended Finance Day 2024 at the analytica trade fair in Munich. The event once again offered exciting expert panels on current financing and capital market issues for life sciences companies. As the panels focused on three of our key consulting areas, namely life sciences, venture capital and IPOs, a visit was of course a must for us as a specialist insurance broker. Our team has

Read more "

Public prosecutor's office investigates: Suspicion of deception in short-time work (Sono Motors)

No startup bonus for criminal and administrative offenses. The incident and possible insurance coverage. As exclusively researched by the team led by Hannah Schwär from Capital Magazine, the founders of Sono Motors are now also threatened with problems with the public prosecutor's office. According to Capital Magazine, subsidy fraud is in the context of short-time work and the programs related to the Corona crisis. The company, which is listed on the NASDAQ via De-SPAC, was reported to the SEC

Read more "

Earnings Call: one 0 too many - the Lyft CEO mistake

"Look, it was a bad mistake, and that's on me," CEO of LYFT Inc. The incident and possible insurance coverage. You may have also heard about the recent incident with LYFT. In the quarterly earnings report, LYFT originally stated that profit margins were up 500 basis points before correcting this to 50 basis points during the conference call. This clerical error caused the share price to fall more than 60% in after-hours trading.

Read more "

We provide information on liability risks for VC funds in the VC Magazine

In December, we were asked by VC-Magazin whether we could provide insights into liability and risk management issues relating to venture capital funds. With pleasure! Together with the team, Florian not only provided insights into current challenges, but also suggested practical solutions to effectively minimize and sensibly transfer the risks of a VC fund. You will therefore find in the VC-Magazin article: Added value of customized insurance concepts for VC funds (focus: D&O/E&O insurance #Moonshot Protect), key measures for risk prevention

Read more "

Known from:

You have questions -
we solve them!

1

Your question to us

We are highly specialized, so we can tell you immediately whether this is within our area of expertise (e.g. fire insurance for a sawmill is not), a D&O program for a NASDAQ listing is.

2

Advice & proposed solution

As an independent insurance broker, we work with all insurers relevant to our specializations in the continental European and UK markets - one of our USPs. As part of our consultation, we discuss with you the optimal marketing strategy for your risk for our tender.

Franziska Merz

Senior Risk Advisor Financial Lines

3

Market comparison & recommendation

Depending on your specific needs—whether it’s D&O insurance through a single insurer or a structured program involving 10 insurers—we’ll present you with the options available on the market based on our client-friendly product solutions (e.g., Risk Partners D&O Prime Protect 2024), with no obligation on your part.

Does our proposal address your needs? You decide whether you’d like us to implement our proposal for you.

4

Promise of care

Your risk changes (e.g. new financing round) or the insurance market changes, we discuss with you possible adjustment options or urgent need for change. Claims? You call us first and we take over for you at eye level with the insurers.
Risk Partners, your insurance experts!